CD8A and Zika virus infectious disease: Heterologous DNA-ZIKV/MVA-ZIKV prime/boost immunization maintains higher magnitude of memory ZIKV-specific CD4+ and CD8+ T cell immune responses than the homologous vector combinations. Memory cellular immune responses are also important for protection against ZIKV infection [38].